{
  "retracted": false,
  "timestamp": 1552348800000,
  "updates": [
    {
      "timestamp": 1583889056375,
      "identifier": {
        "doi": "10.1038/s41598-019-40291-5"
      },
      "type": "correction"
    }
  ],
  "identifier": {
    "doi": "10.1038/s41598-018-30072-x"
  },
  "publisher": "Springer Science and Business Media LLC",
  "title": "Author Correction: Angiopep-2/IP10-EGFRvIIIscFv modified nanoparticles and CTL synergistically inhibit malignant glioblastoma"
}
